Ex Vivo and In Vivo Biological Effects of a Truncated Form of the Receptor Tyrosine Kinase Stk When Activated by Interaction with the Friend Spleen Focus-Forming Virus Envelope Glycoprotein or by Point Mutation
- 1 May 2004
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 78 (9) , 4573-4581
- https://doi.org/10.1128/jvi.78.9.4573-4581.2004
Abstract
The erythroleukemia-inducing Friend spleen focus-forming virus (SFFV) encodes a unique envelope protein, gp55, which interacts with the erythropoietin (Epo) receptor complex, causing proliferation and differentiation of erythroid cells in the absence of Epo. Susceptibility to SFFV-induced erythroleukemia is conferred by the Fv-2 gene, which encodes a short form of the receptor tyrosine kinase Stk/Ron (sf-Stk) only in susceptible strains of mice. We recently demonstrated that sf-Stk becomes activated by forming a strong interaction with SFFV gp55. To examine the biological consequences of activated sf-Stk on erythroid cell growth, we prepared retroviral vectors which express sf-Stk, either in conjunction with gp55 or alone in a constitutively activated mutant form, and tested them for their ability to induce Epo-independent erythroid colonies ex vivo and disease in mice. Our data indicate that both gp55-activated sf-Stk and the constitutively activated mutant of sf-Stk induce erythroid cells from Fv-2 -susceptible and Fv-2 -resistant (sf-Stk null) mice to form Epo-independent colonies. Mutational analysis of sf-Stk indicated that a functional kinase domain and 8 of its 12 tyrosine residues are required for the induction of Epo-independent colonies. Further studies demonstrated that coexpression of SFFV gp55 with sf-Stk significantly extends the half-life of the kinase. When injected into Fv-2 -resistant mice, neither the gp55-activated sf-Stk nor the constitutively activated mutant caused erythroleukemia. Surprisingly, both Fv-2 -susceptible and -resistant mice injected with the gp55-sf-Stk vector developed clinical signs not previously associated with SFFV-induced disease. We conclude that sf-Stk, activated by either point mutation or interaction with SFFV gp55, is sufficient to induce Epo-independent erythroid colonies from both Fv-2 -susceptible and -resistant mice but is unable to cause erythroleukemia in Fv-2 -resistant mice.Keywords
This publication has 32 references indexed in Scilit:
- Preinfection Treatment of Resistant Mice with CpG Oligodeoxynucleotides Renders Them Susceptible to Friend Retrovirus-Induced LeukemiaJournal of Virology, 2003
- Mutations in the met Oncogene Unveil a “Dual Switch” Mechanism Controlling Tyrosine Kinase ActivityJournal of Biological Chemistry, 2003
- A naturally occurring point substitution in Cdc25A, and not Fv2/Stk, is associated with altered cell-cycle status of early erythroid progenitor cellsBlood, 2002
- Sf-Stk kinase activity and the Grb2 binding site are required for Epo-independent growth of primary erythroblasts infected with Friend virusOncogene, 2002
- Requirement of Both Tyrosine Residues 1330 and 1337 in the C-Terminal Tail of the RON Receptor Tyrosine Kinase for Epithelial Cell Scattering and MigrationBiochemical and Biophysical Research Communications, 2000
- Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomasNature Genetics, 1997
- Overexpression of theMET/HGF receptor in ovarian cancerInternational Journal of Cancer, 1994
- Production of high-titer helper-free retroviruses by transient transfection.Proceedings of the National Academy of Sciences, 1993
- Friend virus replication in normal and immunosuppressed C57BL/6 MiceVirology, 1990
- Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism.Proceedings of the National Academy of Sciences, 1990